TMIGD2 Antibody [8G1]

Primary Antibodies

Blue Ice

Predicted: 28 kDa
Observed: 28 kDa

TMIGD2 Antibody: TMIGD2 (transmembrane and immunoglobulin domain containing 1), also known as immunoglobulin-containing and proline-rich receptor 1 (IGPR1), is novel adhesion molecule that is expressed in multiple tissues, primarily in cells of epithelium and endothelium origins (1). TMIGD2 is thought to be involved in angiogenesis and regulates cellular morphology, homophilic cell aggregation, and cell-cell interaction. TMIGD2 activity also modulates actin stress fiber formation and focal adhesion and reduces cell migration.

Trial Size

126259

1 mg/mL

TMIGD2 antibody can be used for ELISA starting at 0.25 μ g/mL. For Western blot start at 0.25 μ g/mL. For Immunocytochemistry start at 2 μ g/mL. For Immunofluorescence start at 20 μ g/mL. For Immunohistochemistry start at 5 μ g/mL.

Monoclonal

Homo sapiens

Optimal dilutions for each application to be determined by the researcher.